As the senior national correspondent at Kaiser Health News, Sarah Varney covers health policy, specifically looking at federal law and how it rolls out in states and local jurisdictions. During her conversation with Patricia Salber, MD, MBA, of The Doctor Weighs In, she explained how her articles are shaped by the time she spends in the field talking to people affected by the policy decisions made in Washington, DC, or state capitals.
As the senior national correspondent at Kaiser Health News, Sarah Varney covers health policy, specifically looking at federal law and how it rolls out in states and local jurisdictions. During her conversation with Patricia Salber, MD, MBA, of The Doctor Weighs In, she explained how her articles are shaped by the time she spends in the field talking to people affected by the policy decisions made in Washington, DC, or state capitals.
Recently, she spent time in Houston, Texas, to talk to people recovering from Hurricane Harvey about the challenges they faced in getting treatment after the storm. They also discussed getting a better perspective of people’s lives and how health policy will impact them.
Listen below or through one of these podcast services:
iTunes: http://apple.co/2eYWTss
TuneIn: http://bit.ly/2gv7iwj
Stitcher: http://bit.ly/2gCqtFg
Review Emphasizes Potential Infection Risks With BTK Inhibitors
November 2nd 2024Although Bruton tyrosine kinase (BTK) inhibitor monotherapy in chronic lymphocytic leukemia (CLL) has been a game-changer, patients have significantly increased risks of infection, especially in the upper respiratory tract.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
PAH Treatment Outcomes Similar Regardless of Diagnosis Time
November 1st 2024The study findings underscore the importance of early initiation of macitentan and tadalafil among patients who have pulmonary arterial hypertension (PAH), and represent a shift in understanding of prognosis based on diagnosis timing.
Read More